OncoCyte Corp Capital Reinvestment Ratio
Latest as of September 2014:
1.86x
OncoCyte Corp capital reinvestment ratio. OncoCyte Corp (OCX) has a Capital Reinvestment Ratio of 1.86x as of September 2014, meaning it reinvests 2% of its operating cash flow ($7.00K) in capital expenditures ($13.00K). See OncoCyte Corp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.86x
Capex / Operating Cash Flow
Operating Cash Flow
$7.00K
USD
Capital Expenditures
$13.00K
USD
Data as of
Sep 2014
Most recent filing
OncoCyte Corp Capital Reinvestment Ratio by Year (None–None)
OncoCyte Corp capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of OncoCyte Corp.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow